Doctor profile · Federal record
Dr. Holavanahall Keshava-Prasad, MD
Hematology & Oncology Physician (CMS: Hematology/Oncology) · Internal Medicine Physician · Las Vegas, NV
- NPI 1437100773
- Accepts Medicare
- MIPS 92.9 / 100 · 2023
- 45 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
3730 S Eastern Ave
Las Vegas, NV 89169
(702) 952-3400
fax (702) 952-3461 - Mailing address
-
400 N Stephanie St, Suite 300
Henderson, NV 890146676
Credentials & registration
- NPI registered
- May 2006 — 20 yrs on file
- Profile last updated
- September 17, 2019
- Year of graduation
- 1981 — 45 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State license (1)
- Nevada #8823
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1437100773. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
137,601
Distinct HCPCS
10
Medicare allowed
$1,305,893
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
Q5101 |
Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram | 43,980 | 18 | $0 | |
J0881 |
Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 30,360 | 30 | $3 | |
Q0138 |
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 26,520 | 27 | $1 | |
J9271 |
Injection, pembrolizumab, 1 mg | 9,205 | 12 | $54 | |
J1453 |
Injection, fosaprepitant, 1 mg | 6,300 | 12 | $0 | |
Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 4,000 | 38 | $0 | |
J0897 |
Injection, denosumab, 1 mg | 3,420 | 20 | $22 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 1,932 | 51 | $0 | |
85025 |
Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 1,299 | 293 | $8 | |
36415 |
Insertion of needle into vein for collection of blood sample | 1,277 | 287 | $8 |
In context: peer comparison
Among 14 peers in Las Vegas Hematology & Oncology Physician, average services per provider: 2,513. This provider delivers 55× the peer median.Open Payments
Industry payments received
All-time total
$12,105
Transactions
165
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| AstraZeneca Pharmaceuticals Lp | 6 | $4,430.65 | |
| BeiGene USA, INC. | 6 | $2,053.64 | |
| Genzyme Corporation | 3 | $1,639.20 | |
| Aveo Pharmaceuticals, INC. | 1 | $910.00 | |
| Novartis Pharmaceuticals Corporation | 27 | $749.48 | |
| Daiichi Sankyo INC. | 52 | $526.89 | |
| Sobi, INC | 15 | $336.16 | |
| Exelixis INC. | 12 | $310.60 | |
| Gilead Sciences, INC. | 9 | $257.34 | |
| Pfizer INC. | 11 | $139.20 | |
| Emd Serono, INC. | 6 | $114.25 | |
| E.R. Squibb & Sons, L.L.C. | 6 | $96.74 | |
| Merck Sharp & Dohme LLC | 4 | $89.34 | |
| Incyte Corporation | 3 | $78.95 | |
| Abbvie INC. | 4 | $62.71 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
507
Patients
66
Total drug cost
$1,748,249
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Oxycodone Hcl | Generic | 79 | 31 | $3,097 |
| Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) | Brand | 47 | 12 | $1,823 |
| Eliquis (Apixaban) | Brand | 43 | 11 | $31,341 |
| Lenalidomide | Generic | 38 | 0 | $593,430 |
| Dexamethasone | Generic | 34 | 0 | $558 |
| Imatinib Mesylate | Generic | 32 | 0 | $44,820 |
| Levothyroxine Sodium | Generic | 30 | 0 | $392 |
| Xarelto (Rivaroxaban) | Brand | 30 | 0 | $28,423 |
| Erleada (Apalutamide) | Brand | 27 | 0 | $435,102 |
| Pomalyst (Pomalidomide) | Brand | 27 | 0 | $607,379 |
Hospital affiliations
Frequently asked questions
What is Dr. Holavanahall Keshava-Prasad's medical specialty?
Dr. Holavanahall Keshava-Prasad practices Hematology & Oncology Physician in Las Vegas, NV.
Where does Dr. Holavanahall Keshava-Prasad practice?
Dr. Holavanahall Keshava-Prasad practices at 3730 S Eastern Ave, Las Vegas, NV 89169. Office phone: 7029523400.
What is Dr. Holavanahall Keshava-Prasad's NPI?
Dr. Holavanahall Keshava-Prasad's National Provider Identifier (NPI) is 1437100773, issued by NPPES.
Does Dr. Holavanahall Keshava-Prasad accept Medicare assignment?
Yes. Dr. Holavanahall Keshava-Prasad accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Holavanahall Keshava-Prasad commonly perform?
Top Medicare-reported procedures in 2023: Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram (HCPCS Q5101); Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS J0881); Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS Q0138). Source: CMS Medicare Physician & Other Practitioners file.